Literature DB >> 23927757

High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.

D Girlich1, N Bouihat, L Poirel, A Benouda, P Nordmann.   

Abstract

Carbapenemase-producing Enterobacteriaceae isolates are being increasingly reported, particularly from countries surrounding the Mediterranean area. We aimed to quantify the prevalence of carbapenemase- and extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in rectal swabs from hospitalized patients in a University hospital in Morocco, and to compare the performance of three screening media: ChromID ESBL (bioMérieux), Brilliance CRE (OXOID, Thermofisher) and SUPERCARBA (home made). Genetic detection and plasmid analysis were performed by PCR and sequencing. Strain comparison was performed by multi-locus sequence typing and the Diversilab technique (bioMérieux). The prevalence of multidrug-resistant Enterobacteriaceae was high, with 33 ESBL producers (42.85%, mainly CTX-M-15) and 10 OXA-48 producers (13%), corresponding to two major clones of K. pneumoniae (70%) and a clone of Enterobacter cloacae (30%). The three screening media showed the same sensitivity for detection of carbapenemase-producing Enterobacteriaceae, whereas the SUPERCARBA medium was more specific than the two other media. The average faecal carriage of ESBL or carbapenemase-producing Enterobacteriaceae varied from 1 × 10(2) to >1 × 10(8) CFU/g of stools. This study shows a high prevalence of multidrug-resistant Enterobacteriaceae, and particularly of OXA-48 producers. The new carbapenem-containing medium, SUPERCARBA, was as sensitive as Brilliance CRE and ChromID ESBL, and more specific for the detection of Enterobacteriaceae expressing those carbapenemases.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Multidrug-resistant bacteria; prevalence; stools

Mesh:

Substances:

Year:  2013        PMID: 23927757     DOI: 10.1111/1469-0691.12325

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  41 in total

Review 1.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in southern France.

Authors:  A Pantel; H Marchandin; M-F Prère; A Boutet-Dubois; N Brieu-Roche; A Gaschet; A Davin-Regli; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-23       Impact factor: 3.267

Review 3.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48.

Authors:  H Solgi; F Badmasti; Z Aminzadeh; C G Giske; M Pourahmad; F Vaziri; S A Havaei; F Shahcheraghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-21       Impact factor: 3.267

Review 5.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

6.  Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey.

Authors:  P Zarakolu; K M Day; H E Sidjabat; W Kamolvit; C V Lanyon; S P Cummings; D L Paterson; M Akova; J D Perry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-12       Impact factor: 3.267

7.  Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.

Authors:  Jonathan A Otter; Eleonora Dyakova; Karen N Bisnauthsing; Antonio Querol-Rubiera; Amita Patel; Chioma Ahanonu; Olga Tosas Auguet; Jonathan D Edgeworth; Simon D Goldenberg
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

Review 8.  Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Authors:  Sandra S Richter; Dror Marchaim
Journal:  Virulence       Date:  2016-11-04       Impact factor: 5.882

9.  First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria.

Authors:  A Agabou; A Pantel; Z Ouchenane; N Lezzar; S Khemissi; D Satta; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-05       Impact factor: 3.267

10.  OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014-2015.

Authors:  Jesús Machuca; Lorena López-Cerero; Felipe Fernández-Cuenca; Laura Mora-Navas; Concepción Mediavilla-Gradolph; Inmaculada López-Rodríguez; Álvaro Pascual
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.